NM_002844.4:c.3016G>A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002844.4(PTPRK):c.3016G>A(p.Val1006Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000297 in 1,611,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002844.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTPRK | NM_002844.4 | c.3016G>A | p.Val1006Ile | missense_variant | Exon 21 of 30 | ENST00000368226.9 | NP_002835.2 | |
PTPRK | NM_001291981.2 | c.3082G>A | p.Val1028Ile | missense_variant | Exon 24 of 33 | NP_001278910.1 | ||
PTPRK | NM_001135648.3 | c.3034G>A | p.Val1012Ile | missense_variant | Exon 22 of 31 | NP_001129120.1 | ||
PTPRK | NM_001291984.2 | c.3013G>A | p.Val1005Ile | missense_variant | Exon 21 of 30 | NP_001278913.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000798 AC: 20AN: 250762Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135562
GnomAD4 exome AF: 0.000315 AC: 459AN: 1459252Hom.: 0 Cov.: 30 AF XY: 0.000292 AC XY: 212AN XY: 726090
GnomAD4 genome AF: 0.000125 AC: 19AN: 152050Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.3034G>A (p.V1012I) alteration is located in exon 22 (coding exon 22) of the PTPRK gene. This alteration results from a G to A substitution at nucleotide position 3034, causing the valine (V) at amino acid position 1012 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at